Major depressive disorder in breast cancer: A critical systematic review of pharmacological and psychotherapeutic clinical trials

Cancer Treatment Reviews

Volumn 40, Issue 3, 2014, Pages 349-355

  Carvalho, André F ^a   Hyphantis, Thomas ^b   Sales, Paulo Marcelo G ^a   Soeiro de Souza, Márcio G ^c   Macêdo, Danielle S ^a   Cha, Danielle S ^d,e   McIntyre, Roger S ^d,e,f   Pavlidis, Nicholas ^b  

^a FEDERAL UNIVERSITY OF CEARÁ   (Brazil)

^b UNIVERSITY OF IOANNINA   (Greece)

^c UNIVERSITY OF SÃO PAULO   (Brazil)

^d UNIVERSITY HEALTH NETWORK   (Canada)

^e UNIVERSITY OF TORONTO   (Canada)

^f UNIVERSITY OF TORONTO   (Canada)

Author keywords

Antidepressant agents; Breast neoplasms; Clinical trials; Depression; Psychotherapy; Systematic review

Indexed keywords

ANTIDEPRESSANT AGENT; DESIPRAMINE; MIANSERIN; PAROXETINE;

BECK DEPRESSION INVENTORY; BREAST CANCER; CANCER RADIOTHERAPY; DRUG EFFICACY; DRUG TOLERABILITY; GROUP THERAPY; HAMILTON SCALE; HOSPITAL ANXIETY AND DEPRESSION SCALE; HUMAN; MAJOR DEPRESSION; MONTGOMERY ASBERG DEPRESSION RATING SCALE; PRACTICE GUIDELINE; PSYCHOTHERAPY; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SYSTEMATIC REVIEW; TREATMENT OUTCOME;

ANTIDEPRESSANT AGENTS; BREAST NEOPLASMS; CLINICAL TRIALS; DEPRESSION; PSYCHOTHERAPY; SYSTEMATIC REVIEW;

ANTIDEPRESSIVE AGENTS; BREAST NEOPLASMS; CLINICAL TRIALS AS TOPIC; DEPRESSIVE DISORDER, MAJOR; FEMALE; HUMANS; INCIDENCE; PSYCHOTHERAPY; WORLD HEALTH;

EID: 84892886145     PISSN: 03057372     EISSN: 15321967     Source Type: Journal    
DOI: 10.1016/j.ctrv.2013.09.009     Document Type: Review

References (47)

1. Ferlay J., Shin H.R., Bray F., Forman D., Mathers C., Parkin D.M. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer J Int du Cancer 2010, 127:2893-2917.
2. Holleczek B., Brenner H. Trends of population-based breast cancer survival in Germany and the US: decreasing discrepancies, but persistent survival gap of elderly patients in Germany. BMC cancer 2012, 12:317.
3. Iwatani T., Matsuda A., Kawabata H., Miura D., Matsushima E. Predictive factors for psychological distress related to diagnosis of breast cancer. Psycho-oncology 2013, 22:523-529.
4. Weinberger T., Forrester A., Markov D., Chism K., Kunkel E.J. Women at a dangerous intersection: diagnosis and treatment of depression and related disorders in patients with breast cancer. Psychiatr Clin North Am 2010, 33:409-422.
5. Fann J.R., Thomas-Rich A.M., Katon W.J., Cowley D., Pepping M., McGregor B.A., et al. Major depression after breast cancer: a review of epidemiology and treatment. Gen Hosp Psychiat 2008, 30:112-126.
6. Mom C.H., Buijs C., Willemse P.H., Mourits M.J., de Vries E.G. Hot flushes in breast cancer patients. Critical reviews in oncology/hematology. 2006, 57:63-77.
7. Fingeret M.C., Nipomnick S.W., Crosby M.A., Reece G.P. Developing a theoretical framework to illustrate associations among patient satisfaction, body image and quality of life for women undergoing breast reconstruction. Cancer Treat Rev 2013, 39:673-681.
8. Safarinejad M.R., Shafiei N., Safarinejad S. Quality of life and sexual functioning in young women with early-stage breast cancer 1 year after lumpectomy. Psycho-oncology 2013, 22:1242-1248.
9. Kim J.M., Stewart R., Kim S.Y., Kang H.J., Jang J.E., Kim S.W., et al. A one year longitudinal study of cytokine genes and depression in breast cancer. J Affect Disord 2013, 148:57-65.
10. Kim J.M., Kim S.W., Stewart R., Kim S.Y., Shin I.S., Park M.H., et al. Serotonergic and BDNF genes associated with depression 1 week and 1 year after mastectomy for breast cancer. Psychosom Med 2012, 74:8-15.
11. Delgado-Sanz M.C., Garcia-Mendizabal M.J., Pollan M., Forjaz M.J., Lopez-Abente G., Aragones N., et al. Heath-related quality of life in Spanish breast cancer patients: a systematic review. Health Qual Life Out 2011, 9:3.
12. Passik S.D., Dugan W., McDonald M.V., Rosenfeld B., Theobald D.E., Edgerton S. Oncologists' recognition of depression in their patients with cancer. J Clin Oncol 1998, 16:1594-1600.
13. Network NCC. Distress management. NCCN Clinical Practice Guidelines in Oncology; 2008.
14. Zainal N.Z., Booth S., Huppert F.A. The efficacy of mindfulness-based stress reduction on mental health of breast cancer patients: a meta-analysis. Psycho-oncology 2013, 22:1457-1465.
15. Naaman S.C., Radwan K., Fergusson D., Johnson S. Status of psychological trials in breast cancer patients: a report of three meta-analyses. Psychiatry 2009, 72:50-69.
16. Moher D., Liberati A., Tetzlaff J., Altman D.G. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 2009, 6:e1000097.
17. Frist MB, Spitzer RL, Gibbon M, Williams J. Structured Clinical Interview for DSM-IV Axis I Disorders - Patient Edition (SCID-I/P, Version 2.0). New York: Biometrics Research Department, New York Pychiatric Institute; 1996.
18. Wittchen H.U. Reliability and validity studies of the WHO-Composite International Diagnostic Interview (CIDI): a critical review. J Psychiatr Res 1994, 28:57-84.
19. Robins L.N., Helzer J.E., Croughan J., Ratcliff K.S. National institute of mental health diagnostic interview schedule. Its history, characteristics, and validity. Arch Gen Psychiatry 1981, 38:381-389.
20. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960, 23:56-62.
21. Montgomery S.A., Asberg M. A new depression scale designed to be sensitive to change. Br J Psychiatry J Mental Sci 1979, 134:382-389.
22. Higgins JPT, Altman, DG. Assessing risk of bias in included studies. In: Higgins JPT, Altman DG, Sterne JAC, editor. Cochrane handbook for systematic reviews of interventions version 510 [updated March 2011]: The Cochrane Collaboration; 2011.
23. van Heeringen K., Zivkov M. Pharmacological treatment of depression in cancer patients. A placebo-controlled study of mianserin. Br J Psychiatry J Mental Sci 1996, 169:440-443.
24. Musselman D.L., Somerset W.I., Guo Y., Manatunga A.K., Porter M., Penna S., et al. A double-blind, multicenter, parallel-group study of paroxetine, desipramine, or placebo in breast cancer patients (stages I, II, III, and IV) with major depression. J Clin Psychiatry 2006, 67:288-296.
25. Savard J., Simard S., Giguere I., Ivers H., Morin C.M., Maunsell E., et al. Randomized clinical trial on cognitive therapy for depression in women with metastatic breast cancer: psychological and immunological effects. Palliat Support Care 2006, 4:219-237.
26. Simpson J.S., Carlson L.E., Trew M.E. Effect of group therapy for breast cancer on healthcare utilization. Cancer Pract 2001, 9:19-26.
27. Egger M., Davey Smith G., O'Rourke K. Rationale, potentials, and promise of systematic reviews. Systematic reviews in health care: meta-analysis in context 2001, 3-22. BMJ Books, London. 2nd ed. M. Egger, G. Davey Smith, D.G. Altman (Eds.).
28. Taylor D., Meader N., Bird V., Pilling S., Creed F., Goldberg D. Pharmacological interventions for people with depression and chronic physical health problems: systematic review and meta-analyses of safety and efficacy. Br J Psychiatry J Mental Sci 2011, 198:179-188.
29. Walker J., Sawhney A., Hansen C.H., Ahmed S., Martin P., Symeonides S., et al. Treatment of depression in adults with cancer: a systematic review of randomized controlled trials. Psychol Med 2013, 1-11.
30. Nguyen J., Cramarossa G., Bruner D., Chen E., Khan L., Leung A., et al. A literature review of symptom clusters in patients with breast cancer. Expert Rev Pharmacoecon Outcomes Res 2011, 11:533-539.
31. Pinto A.C., de Azambuja E. Improving quality of life after breast cancer: dealing with symptoms. Maturitas 2011, 70:343-348.
32. Roscoe J.A., Morrow G.R., Hickok J.T., Mustian K.M., Griggs J.J., Matteson S.E., et al. Effect of paroxetine hydrochloride (Paxil) on fatigue and depression in breast cancer patients receiving chemotherapy. Breast Cancer Res Treat 2005, 89:243-249.
33. Kimmick G.G., Lovato J., McQuellon R., Robinson E., Muss H.B. Randomized, double-blind, placebo-controlled, crossover study of sertraline (Zoloft) for the treatment of hot flashes in women with early stage breast cancer taking tamoxifen. Breast J 2006, 12:114-122.
34. Barbui C., Cipriani A., Patel V., Ayuso-Mateos J.L., van Ommeren M. M. Efficacy of antidepressants and benzodiazepines in minor depression: systematic review and meta-analysis. Br J Psychiatry J Mental Sci 2011, 198(Suppl. 1):11-16.
35. Fournier J.C., DeRubeis R.J., Hollon S.D., Dimidjian S., Amsterdam J.D., Shelton R.C., et al. Antidepressant drug effects and depression severity: a patient-level meta-analysis. JAMA J Am Med Assoc 2010, 303:47-53.
36. Early Breast Cancer Trialists' Collaborative G. Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet 2005, 365:1687-1717.
37. Henry N.L., Stearns V., Flockhart D.A., Hayes D.F., Riba M. Drug interactions and pharmacogenomics in the treatment of breast cancer and depression. Am J Psychiatry 2008, 165:1251-1255.
38. Margolin S., Lindh J.D., Thoren L., Xie H., Koukel L., Dahl M.L., et al. CYP2D6 and adjuvant tamoxifen: possible differences of outcome in pre- and post-menopausal patients. Pharmacogenomics 2013, 14:613-622.
39. Spina E., Trifiro G., Caraci F. Clinically significant drug interactions with newer antidepressants. CNS Drugs 2012, 26:39-67.
40. Desmarais J.E., Looper K.J. Interactions between tamoxifen and antidepressants via cytochrome P450 2D6. J Clin Psychiatry 2009, 70:1688-1697.
41. Zembutsu H., Sasa M., Kiyotani K., Mushiroda T., Nakamura Y. Should CYP2D6 inhibitors be administered in conjunction with tamoxifen?. Expert Rev Anticancer Ther 2011, 11:185-193.
42. Kelly C.M., Juurlink D.N., Gomes T., Duong-Hua M., Pritchard K.I., Austin P.C., et al. Selective serotonin reuptake inhibitors and breast cancer mortality in women receiving tamoxifen: a population based cohort study. Bmj 2010, 340:c693.
43. Stearns V., Johnson M.D., Rae J.M., Morocho A., Novielli A., Bhargava P., et al. Active tamoxifen metabolite plasma concentrations after coadministration of tamoxifen and the selective serotonin reuptake inhibitor paroxetine. J National Cancer Inst 2003, 95:1758-1764.
44. Galway K., Black A., Cantwell M., Cardwell C.R., Mills M., Donnelly M. Psychosocial interventions to improve quality of life and emotional wellbeing for recently diagnosed cancer patients. Cochrane Database Syst Rev 2012, 11:CD007064.
45. Ioannidis J.P. Why most published research findings are false. PLoS Med 2005, 2:e124.
46. Coyne J.C., Thombs B.D., Hagedoorn M. Ain't necessarily so: review and critique of recent meta-analyses of behavioral medicine interventions in health psychology. Health Psychol. 2010, 29:107-116.
47. Schneider S., Moyer A., Knapp-Oliver S., Sohl S., Cannella D., Targhetta V. Pre-intervention distress moderates the efficacy of psychosocial treatment for cancer patients: a meta-analysis. J Behav Med 2010, 33:1-14.